Meridian Co., Ltd.

Meridian Co., Ltd.

January 06, 2005 09:01 ET

Meridian to Attend 2nd Annual Scripp's Natural Supplements Conference Along with Dr. Barry Sears and Thorne Research, Inc.



OTC Bulletin Board SYMBOL: MRDAF

JANUARY 6, 2005 - 09:01 ET

Meridian to Attend 2nd Annual Scripp's Natural
Supplements Conference Along with Dr. Barry Sears and
Thorne Research, Inc.

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jan. 6, 2005) - Meridian
Co., Ltd. ("Meridian" or the "Company") (OTCBB:MRDAF), is pleased to
announce it will be attending the 2nd Annual Scripp's Natural
Supplements Conference from January 7 - 9, 2005, at the Hilton Torrey
Pines in La Jolla, California. The Scripps Center for Integrative
Medicine will host this three day conference, which will include more
than two dozen nationally renowned medical experts presenting an
evidence-based, comprehensive overview of natural supplements to a wide
variety of health care providers such as physicians, nurses,
pharmacists, dieticians, as well as the general public.

"This conference provides a comprehensive experience for health care
providers and others who want to understand nutritional supplements,"
says Dr. Mimi Guarneri, conference director and founder and medical
director of the Scripps Center for Integrative Medicine. "Our goal in
creating this conference is to raise awareness of herbal and natural
remedies and enhance the credibility of integrative medicine among our

Meridian believes this conference will be an ideal forum to network with
wellness practitioners from across the United States and to continue to
build relationships within the neutraceutical industry. Meridian will
also have the opportunity to meet with existing client Dr. Barry Sears,
renowned research scientist and famed creator of the Zone Diet, as well
as with Thorne Research, Inc., who began collaborating with Meridian in
2004 to facilitate clinical studies using the Digital Pulse Analyzer
("DPA") as well as including Meridian's promotional literature with
Thorne's product orders and mail-outs to physicians across North

Meridian's FDA approved, non-invasive DPA is a perfect fit within this
setting as it's a proven method of detecting whether a particular
treatment option, such as natural supplementation, is effective.

Americans spend more than $10 billion annually on herbal and dietary
supplements. But in today's highly competitive marketplace a
comprehensive supplement in not enough. You need the technology to prove
it! After a client or patient's initial screening with the DPA, the
client can follow a lifestyle modification program, which can include
diet, exercise, supplementation, or pharmaceutical treatment and then
re-test 30 to 60 days later to monitor their progress.

The conference faculty includes nationally known speakers, clinicians,
authors and researchers such as:

Barry Sears, Ph.D., best selling author, The Zone and The Omega Rx Zone
on "The Wellness Zone: Anti-Inflammatory Diet and Strategies for Optimum

David Eisenberg, M.D., professor and researcher, Harvard Medical School
on "Prevalence and Patterns of Complementary and Alternative Medicine
Use: Focus on Botanicals and Other Dietary Supplements"

Jeffrey Bland, Ph.D., chairman, Institute for Functional Medicine on
"The Nutragenomics of the Metabolic Syndrome"

Mark Blumenthal, founder and executive director of the American
Botanical Council on "Beyond Ephedra: Natural Supplements in Weight

Steven Pratt, M.D., Scripps ophthalmologist and best-selling author of
SuperFoods Rx on "The Role of Anti-Oxidants and Super Nutrients in
Health Promotion and Disease Prevention"

Erminia "Mimi" Guarneri, M.D., Cardiologist, founder and medical
director of the Scripps Center for Integrative Medicine on "Natural
Supplements in Cardiac Care"

Robert Bonakdar, M.D., director of pain management for the Scripps
Center for Integrative Medicine on "Natural Supplements in Pain

More About: Digital Pulse Analyzer ("DPA")

The DPA is an FDA approved device that is inexpensive, non-invasive, and
can provide results in minutes. Accumulating evidence suggests that
abnormalities in the pulsatile characteristics of arteries occur early
in the disease process associated with increased cardiovascular risk,
and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce
cardiovascular disease in their patient populations through early
detection and prevention, and ultimately assist to decrease the
associated financial costs placed on the health care industry.
Cardiovascular disease is the #1 killer in the United States with an
estimated economic cost of approximately $298 billion.

More About: Meridian

Meridian is an established leader in the research/development,
manufacturing, and sales of integrative medical diagnostic equipment.
The company sells its products and equipment to a wide array of
customers in the global health care industry. The company presently
holds a total of 18 worldwide patents on its technology, and has
received FDA, as well as other international regulatory approvals for
many of its products.

Meridian is committed to the ongoing global research and advancement of
integrative medical products that contribute to the better health of

Website (Korean):

Website (North America):


Contact Information

    Meridian Co., Ltd.
    Greg Worobec
    Corporate Communications